A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
NCT04805905 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2021-03-18
Summary
A prospective single-centered feasibility study will be conducted. The purpose of the feasibility study is to define the variables to be included in a subsequent pilot study, assess the feasibility of conducting a prospective cohort study, and the logistics for the study (i.e., training, patient recruitment, data collection, statistical analysis, etc.).
Conditions
- Skin Cancer, Basal Cell
- Skin Cancer
- Skin Cancer, Non-Melanoma
- Skin Cancers - Squamous Cell Carcinoma
- Patient Satisfaction
Interventions
- OTHER
-
FACE-Q patient reported outcome
As both interventions of treatment are gold standards and clinical equipoise exists if one intervention is superior to the other, there is no true control group. However, for the purpose of the application, the local flap group will be chosen as the "control" group. Skin graft (Experimental): Participants in the experimental group will receive a skin graft and receive the FACE-Q skin cancer questionnaire pre- and post-treatment. There will also be photos taken of the patient's face along with the distributed questionnaires. Local flap (Control): Participants in the experimental group will receive a local flap and receive the FACE-Q questionnaire pre- and post-treatment.
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-30
- Primary Completion
- 2021-06-30
- Completion
- 2022-02-28
More Related Trials
-
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222 ·Status: RECRUITING
-
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
NCT03969004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
NCT00601185 ·Status: COMPLETED
-
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
NCT05402059 ·Status: UNKNOWN
-
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
NCT04975152 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT07228442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
NCT01781572 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
NCT06568172 ·Status: SUSPENDED ·Phase: PHASE3
-
An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence
NCT02296970 ·Status: COMPLETED
-
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
NCT02270645 ·Status: COMPLETED ·Phase: NA
-
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
NCT02094872 ·Status: COMPLETED ·Phase: PHASE2
-
Buddy Relationships in DermatoloGic Excisions for Skin Cancer
NCT04036344 ·Status: COMPLETED ·Phase: NA
-
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
NCT03291002 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of AFL-assisted PDT in Microinvasive Squamous Cell Carcinoma
NCT02666534 ·Status: COMPLETED ·Phase: PHASE1
-
Real World Study on the Use of Cemiplimab in Adult Patients in UK
NCT05493826 ·Status: COMPLETED
-
Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.
NCT06448936 ·Status: RECRUITING
-
FLASH Radiotherapy for Skin Cancer
NCT05724875 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
NCT03492489 ·Status: NO_LONGER_AVAILABLE
-
Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma
NCT06894407 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
NCT03889912 ·Status: COMPLETED ·Phase: PHASE1
-
Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma
NCT06870994 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
NCT05315128 ·Status: COMPLETED ·Phase: PHASE2
-
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
NCT02036476 ·Status: TERMINATED ·Phase: PHASE2
-
MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)
NCT03932253 ·Status: SUSPENDED ·Phase: PHASE1
-
Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
NCT00515970 ·Status: SUSPENDED ·Phase: NA